Profil
Daniel Paul Regan formerly worked at Keryx Biopharmaceuticals, Inc., as Independent Director from 2013 to 2018, Genzyme Corp., as Senior Vice President-US Rare Disease Business from 2010 to 2011, Janssen Pharmaceuticals, Inc., as Head-Sales & Marketing, Intercept Pharmaceuticals, Inc., as Chief Commercial Officer from 2013 to 2015, and Inspiration Biopharmaceuticals, Inc., as Chief Commercial Officer & Senior Vice President in 2012.
Mr. Regan received his Masters Business Admin degree in 2017 from Southern New Hampshire University and undergraduate degree in 1988 from the University of Massachusetts.
Anciens postes connus de Daniel Paul Regan
| Sociétés | Poste | Fin |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Directeur/Membre du Conseil | 12/12/2018 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2015 |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Corporate Officer/Principal | 01/01/2012 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Sales & Marketing | - |
Formation de Daniel Paul Regan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Southern New Hampshire University
Southern New Hampshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















